The ROE (Return on Equity) of Calliditas Therapeutics AB (CALTX.ST) is -139.24%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2023-12-31 | -139.24% |
| 2022-12-31 | -53.80% |
| 2021-12-31 | -49.62% |
| 2020-12-31 | -35.81% |
| 2019-12-31 | -4.13% |
| 2018-12-31 | -21.36% |
| 2017-12-31 | -261.62% |
| 2016-12-31 | 400.14% |
| 2015-12-31 | -282.05% |